These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34509474)

  • 1. The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress.
    Stromberg BR; Singh M; Torres AE; Burrows AC; Pal D; Insinna C; Rhee Y; Dickson AS; Westlake CJ; Summers MK
    J Biol Chem; 2021 Oct; 297(4):101184. PubMed ID: 34509474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP37 deubiquitinates Cdt1 and contributes to regulate DNA replication.
    Hernández-Pérez S; Cabrera E; Amoedo H; Rodríguez-Acebes S; Koundrioukoff S; Debatisse M; Méndez J; Freire R
    Mol Oncol; 2016 Oct; 10(8):1196-206. PubMed ID: 27296872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM.
    Wu C; Chang Y; Chen J; Su Y; Li L; Chen Y; Li Y; Wu J; Huang J; Zhao F; Wang W; Yin H; Wang S; Jin M; Lou Z; Zhu WG; Luo K; Zhang J; Yuan J
    Nucleic Acids Res; 2021 Nov; 49(19):11224-11240. PubMed ID: 34606619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression.
    Chauhan R; Gupta A; Malhotra L; Bhat AA; Pandita RK; Masoodi T; Dagar G; Sadida HQ; Al-Marzooqi SK; Batra A; Bakhshi S; Sharma MC; Tanwar P; Khan SA; Samath EA; Uddin S; Akil ASA; Haris M; Macha MA; Pandita TK; Singh M
    J Transl Med; 2023 Apr; 21(1):286. PubMed ID: 37118828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.
    Nojima H; Homma H; Onozato Y; Kaida A; Harada H; Miura M
    Exp Cell Res; 2020 Jan; 386(2):111720. PubMed ID: 31738907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal CHK1 activity safeguards its stability to maintain intrinsic S-phase checkpoint functions.
    Michelena J; Gatti M; Teloni F; Imhof R; Altmeyer M
    J Cell Biol; 2019 Sep; 218(9):2865-2875. PubMed ID: 31366665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chk1 dynamics in G2 phase upon replication stress predict daughter cell outcome.
    Lebrec V; Poteau M; Morretton JP; Gavet O
    Dev Cell; 2022 Mar; 57(5):638-653.e5. PubMed ID: 35245445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
    Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
    Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation.
    Cheng YC; Shieh SY
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5546-5551. PubMed ID: 29735693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative Chk1-independent S/M checkpoint in somatic cells that prevents premature mitotic entry.
    Zineldeen DH; Shafik NM; Li SF
    Med Oncol; 2017 Apr; 34(4):70. PubMed ID: 28349497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-interacting motifs confer full catalytic activity, but not ubiquitin chain substrate specificity, to deubiquitinating enzyme USP37.
    Tanno H; Shigematsu T; Nishikawa S; Hayakawa A; Denda K; Tanaka T; Komada M
    J Biol Chem; 2014 Jan; 289(4):2415-23. PubMed ID: 24324262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
    Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
    Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase.
    Wayne J; Brooks T; Massey AJ
    Oncotarget; 2016 Dec; 7(51):85033-85048. PubMed ID: 27829224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer.
    Pan J; Deng Q; Jiang C; Wang X; Niu T; Li H; Chen T; Jin J; Pan W; Cai X; Yang X; Lu M; Xiao J; Wang P
    Oncogene; 2015 Jul; 34(30):3957-67. PubMed ID: 25284584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxin-3 promotes genome integrity by stabilizing Chk1.
    Tu Y; Liu H; Zhu X; Shen H; Ma X; Wang F; Huang M; Gong J; Li X; Wang Y; Guo C; Tang TS
    Nucleic Acids Res; 2017 May; 45(8):4532-4549. PubMed ID: 28180282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression.
    Yeh C; Coyaud É; Bashkurov M; van der Lelij P; Cheung SW; Peters JM; Raught B; Pelletier L
    Curr Biol; 2015 Aug; 25(17):2290-9. PubMed ID: 26299517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.
    Huang X; Summers MK; Pham V; Lill JR; Liu J; Lee G; Kirkpatrick DS; Jackson PK; Fang G; Dixit VM
    Mol Cell; 2011 May; 42(4):511-23. PubMed ID: 21596315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human USP3 is a chromatin modifier required for S phase progression and genome stability.
    Nicassio F; Corrado N; Vissers JH; Areces LB; Bergink S; Marteijn JA; Geverts B; Houtsmuller AB; Vermeulen W; Di Fiore PP; Citterio E
    Curr Biol; 2007 Nov; 17(22):1972-7. PubMed ID: 17980597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claspin - checkpoint adaptor and DNA replication factor.
    Smits VAJ; Cabrera E; Freire R; Gillespie DA
    FEBS J; 2019 Feb; 286(3):441-455. PubMed ID: 29931808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
    Yang WC; Shih HM
    Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.